No abstract available
Publication types
-
Clinical Trial
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antiviral Agents / therapeutic use*
-
Drug Therapy, Combination
-
Genotype
-
Hepacivirus / genetics
-
Hepatitis C / drug therapy*
-
Humans
-
Interferon alpha-2
-
Interferon-alpha / therapeutic use*
-
Male
-
Middle Aged
-
Pilot Projects
-
Polyethylene Glycols / therapeutic use*
-
Proline / analogs & derivatives*
-
Proline / therapeutic use
-
RNA, Viral / blood*
-
Recombinant Proteins / therapeutic use
-
Recurrence
-
Ribavirin / therapeutic use*
-
Viral Load
Substances
-
Antiviral Agents
-
Interferon alpha-2
-
Interferon-alpha
-
RNA, Viral
-
Recombinant Proteins
-
Polyethylene Glycols
-
Ribavirin
-
N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
-
Proline
-
peginterferon alfa-2b